FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1772-1773 December 2, 1999 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Niewoehner, D. E. PubMed Citation

To the Editor: Niewoehner et al. (June 24 issue)¹ reported the effects of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease (COPD). They designed their study to evaluate clinical outcomes and found that patients treated with systemic glucocorticoids had a shorter initial hospital stay (8.5 days) than patients who received placebo (9.7 days). They also found, however, that the glucocorticoid-treated patients spent more time in the hospital for reasons other than COPD during the six-month period after their initial hospitalization. With the initial hospital stay added to subsequent stays, the patients in the glucocorticoid group spent about two more . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.